🇪🇺 ESL in European Union

EMA authorised ESL on 21 April 2009

Marketing authorisation

EMA — authorised 21 April 2009

  • Application: EMEA/H/C/000988
  • Marketing authorisation holder: BIAL - Portela & Ca, S.A.
  • Local brand name: Zebinix
  • Indication: Zebinix is indicated as adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.
  • Status: approved

Read official source →

Other Neurology approved in European Union

Frequently asked questions

Is ESL approved in European Union?

Yes. EMA authorised it on 21 April 2009.

Who is the marketing authorisation holder for ESL in European Union?

BIAL - Portela & Ca, S.A. holds the EU marketing authorisation.